Levi & Korsinsky announces that a class action lawsuit has been
commenced in the United States District Court for the District of Oregon
on behalf of holders of Galena Biopharma, Inc. (“Galena” or the
“Company”) (Nasdaq: GALE) securities between November 6, 2013 and
February 14, 2014.
For more information, click here: http://zlk.9nl.com/galenabiopharma-gale.
The complaint alleges that throughout the Class Period, Galena made
false and/or misleading statements that led to the artificial inflation
of Galena’s stock price, allowing its Chief Executive Officer to sell
$3.8 million worth of his Galena stock.
On February 12, 2014, an article featured on TheStreet.com
alleged Galena was engaging in a misleading campaign aimed at boosting
its stock price, alleging that investor relations firm The DreamTeam
Group had published articles under aliases promoting the Company’s stock
without disclosing their sponsorship. Then on February 14, 2014, Galena
acknowledged that it had paid the investor relations firm The DreamTeam
Group to promote the Company.
If you suffered a loss in Galena you have until May 5, 2014 to request
that the Court appoint you as lead plaintiff. Your ability to share in
any recovery doesn’t require that you serve as a lead plaintiff. To
obtain additional information, contact Joseph E. Levi, Esq. either via
email at jlevi@zlk.com or by
telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/galenabiopharma-gale.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut, and Washington D.C. The firm has extensive
expertise in prosecuting securities litigation involving financial
fraud, representing investors throughout the nation in securities and
shareholder lawsuits. Attorney advertising. Prior results do not
guarantee similar outcomes.
Copyright Business Wire 2014